CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
CannaPharmaRx's operating income for the twelve months ending Sep 30, 2026 was -$2.49M. For fiscal 2025 it was -$3.35M. The highest annual figure on record is $585.60K in fiscal 2010.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.35M | – |
| FY2024 | Dec 31, 2024 | -$3.63M | – |
| FY2023 | Dec 31, 2023 | -$1.58M | – |
| FY2022 | Dec 31, 2022 | -$5.21M | – |
| FY2021 | Dec 31, 2021 | -$2.99M | – |
| FY2020 | Dec 31, 2020 | -$14.49M | – |
| FY2019 | Dec 31, 2019 | -$15.98M | – |
| FY2018 | Dec 31, 2018 | -$954.32K | – |
| FY2017 | Dec 31, 2017 | -$6.63K | – |
| FY2016 | Dec 31, 2016 | -$1.00M | – |
| FY2015 | Dec 31, 2015 | -$11.65M | – |
| FY2014 | Dec 31, 2014 | -$3.97M | – |
| FY2013 | Dec 31, 2013 | -$80.31K | – |
| FY2012 | Dec 31, 2012 | -$89.57K | – |
| FY2011 | Dec 31, 2011 | -$97.10K | -116.6% |
| FY2010 | Dec 31, 2010 | $585.60K | +414.9% |
| FY2009 | Dec 31, 2009 | $113.74K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$532.94K | – |
| Q2 FY2026 | Jun 30, 2026 | -$378.83K | – |
| Q1 FY2026 | Mar 31, 2026 | -$682.34K | – |
| Q4 FY2025 | Dec 31, 2025 | -$893.55K | – |
| Q3 FY2025 | Sep 30, 2025 | -$935.65K | – |
| Q2 FY2025 | Jun 30, 2025 | -$840.98K | – |
| Q1 FY2025 | Mar 31, 2025 | -$677.59K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.53M | -318.4% |
| Q3 FY2024 | Sep 30, 2024 | -$515.98K | – |
| Q2 FY2024 | Jun 30, 2024 | -$517.82K | – |
| Q1 FY2024 | Mar 31, 2024 | -$790.20K | – |
| Q4 FY2023 | Dec 31, 2023 | $699.61K | – |
| Q3 FY2023 | Sep 30, 2023 | -$667.50K | – |
| Q2 FY2023 | Jun 30, 2023 | -$892.94K | – |
| Q1 FY2023 | Mar 31, 2023 | -$720.28K | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.20M | – |
| Q3 FY2022 | Sep 30, 2022 | -$588.48K | – |
| Q2 FY2022 | Jun 30, 2022 | -$704.14K | – |
| Q1 FY2022 | Mar 31, 2022 | -$715.56K | – |
| Q4 FY2021 | Dec 31, 2021 | -$704.54K | – |
| Q3 FY2021 | Sep 30, 2021 | -$771.20K | – |
| Q2 FY2021 | Jun 30, 2021 | -$796.08K | – |
| Q1 FY2021 | Mar 31, 2021 | -$721.35K | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.82M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.31M | – |
| Q2 FY2020 | Jun 30, 2020 | -$787.48K | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.57M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.99M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.36M | – |
| Q2 FY2019 | Jun 30, 2019 | -$688.86K | – |
| Q1 FY2019 | Mar 31, 2019 | -$946.92K | – |
| Q4 FY2018 | Dec 31, 2018 | -$703.32K | – |
| Q3 FY2018 | Sep 30, 2018 | -$180.49K | – |
| Q2 FY2018 | Jun 30, 2018 | -$70.50K | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.97K | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | -$70.50K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.67K | – |
| Q4 FY2016 | Dec 31, 2016 | -$36.22K | – |
See a number that looks wrong?